Docosanol - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for docosanol and what is the scope of patent protection?
Docosanol
is the generic ingredient in two branded drugs marketed by Haleon Us Holdings, Alembic, Aurobindo Pharma Ltd, P And L, P And L Development, and Taro, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.There are five drug master file entries for docosanol. Thirty-five suppliers are listed for this compound.
Summary for docosanol
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 6 |
NDAs: | 6 |
Drug Master File Entries: | 5 |
Finished Product Suppliers / Packagers: | 35 |
Raw Ingredient (Bulk) Api Vendors: | 122 |
Clinical Trials: | 1 |
Patent Applications: | 9,710 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for docosanol |
What excipients (inactive ingredients) are in docosanol? | docosanol excipients list |
DailyMed Link: | docosanol at DailyMed |
Recent Clinical Trials for docosanol
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Laboratoire Boreaderme Inc. | Phase 2 |
Ecogene 21 | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for docosanol
US Patents and Regulatory Information for docosanol
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P And L Development | DOCOSANOL | docosanol | CREAM;TOPICAL | 212385-001 | Oct 7, 2022 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Taro | DOCOSANOL | docosanol | CREAM;TOPICAL | 214454-001 | Oct 26, 2023 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
P And L | DOCOSANOL | docosanol | CREAM;TOPICAL | 208754-001 | Nov 19, 2018 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Alembic | DOCOSANOL | docosanol | CREAM;TOPICAL | 215839-001 | May 3, 2022 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Aurobindo Pharma Ltd | DOCOSANOL | docosanol | CREAM;TOPICAL | 217090-001 | Mar 1, 2024 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Haleon Us Holdings | ABREVA | docosanol | CREAM;TOPICAL | 020941-001 | Jul 25, 2000 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for docosanol
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Haleon Us Holdings | ABREVA | docosanol | CREAM;TOPICAL | 020941-001 | Jul 25, 2000 | ⤷ Try a Trial | ⤷ Try a Trial |
Haleon Us Holdings | ABREVA | docosanol | CREAM;TOPICAL | 020941-001 | Jul 25, 2000 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |